L‐Carnitine Attenuates Methotrexate‐Induced Nephrotoxicity by Modulating BAX/BCL2 Apoptotic Signaling and Preserving Podocyte, Endothelial, and Tubular Integrity
Journal of Applied Toxicology · 2026
DOI: 10.1002/jat.70096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2026. Verfasst von Özlem Türkoglu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Hamidiye Faculty of Medicine, University of Health Sciences, İstanbul, Turkey. Hauptthemen laut MEDLINE: Carnitine, Methotrexate, Apoptosis, bcl-2-Associated X Protein. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Süleyman Demirel University, Süleyman Demirel Üniversitesi.
Abstract (Originalsprache)
Methotrexate (MTX), a common chemotherapeutic and immunosuppressive drug, is limited by dose‐dependent nephrotoxicity mediated by oxidative stress, mitochondrial dysfunction, and apoptosis. L‐carnitine (LCR), a mitochondrial cofactor with antioxidant and anti‐apoptotic properties, may counteract these mechanisms. This study aims to determine whether LCR mitigates MTX‐induced nephrotoxicity by rebalancing the BAX/BCL2 apoptotic axis and preserving renal compartment integrity (endothelial CD31, tubular cytokeratin, podocyte WT1). Twenty‐four female Wistar rats were randomized into Control, MTX (20 mg/kg, i.p., Day 5), LCR (200 mg/kg/day, i.p., 10 days), and MTX + LCR groups ( n = 6 each). Renal injury was assessed by serum creatinine, urea, BUN, histopathology, immunohistochemistry (CD31, cytokeratin, WT1), and RT‐qPCR for BAX/BCL2. MTX impaired renal function, caused vascular hyperemia, hemorrhage, and tubular necrosis, increased CD31, cytokeratin, and BAX and decreased WT1 and BCL2. LCR co‐treatment improved biochemical indices, reduced lesions, decreased CD31 and cytokeratin, partially restored WT1 and re‐balanced apoptosis (BAX↓, BCL2↑). LCR disrupts oxidative stress, the mitochondrial apoptosis cascade, and preserves endothelial, tubular, and podocyte integrity in MTX nephrotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Hamidiye Faculty of Medicine, University of Health Sciences, İstanbul, Turkey.
- Department of Genetics, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.
- ProDentalia Dental Clinic, Konyaaltı/Antalya, Turkey.
- Laboratory Animal Production and Experimental Research Center, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.
- Department of Therapy and Rehabilitation, Isparta Vocational School of Health Services, Süleyman Demirel University, Isparta, Turkey.
ORCID-Profile: Özlem Türkoglu, Zafer Usta, Kemal Çavdarlı, Simge Garlı, Nur Alp
Förderung
- Süleyman Demirel University
- Süleyman Demirel Üniversitesi
Zitieren
APA
Türkoglu, Ö., Usta, Z., Çavdarlı, K., Garlı, S., & Alp, N. (2026). L‐Carnitine Attenuates Methotrexate‐Induced Nephrotoxicity by Modulating BAX/BCL2 Apoptotic Signaling and Preserving Podocyte, Endothelial, and Tubular Integrity. Journal of Applied Toxicology. https://doi.org/10.1002/jat.70096
Vancouver
Türkoglu Ö, Usta Z, Çavdarlı K, Garlı S, Alp N. L‐Carnitine Attenuates Methotrexate‐Induced Nephrotoxicity by Modulating BAX/BCL2 Apoptotic Signaling and Preserving Podocyte, Endothelial, and Tubular Integrity. Journal of Applied Toxicology. 2026. doi:10.1002/jat.70096
BibTeX
@article{Trkoglu2026,
author = {Türkoglu, Özlem and Usta, Zafer and Çavdarlı, Kemal and Garlı, Simge and Alp, Nur},
title = {L‐Carnitine Attenuates Methotrexate‐Induced Nephrotoxicity by Modulating BAX/BCL2 Apoptotic Signaling and Preserving Podocyte, Endothelial, and Tubular Integrity},
journal = {Journal of Applied Toxicology},
year = {2026},
doi = {10.1002/jat.70096}
}
EUVIMED